This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Henry J. M. Barnett, MD; Michael Eliasziw, PhD; Heather E. Meldrum

Arch Neurol. 1995;52(8):827-831.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

OVERWHELMING proof exists that ischemie stroke can be prevented, or at least delayed, for a large number of individuals. Many strokes that resulted from severe symptomatic carotid artery stenosis need happen no longer. Effective treatments have been established by the time-consuming and expensive process of randomized clinical trials. Alas, all other methods seeking the truth about therapeutic benefit are less perfect and frequently misleading. Paradoxically, endarterectomy is complicated by stroke, the very disaster that it effectively reduces. This paradox demands of the practitioner that the indications for this therapy and the care with which it is administered must be precisely defined and scrupulously monitored. This communication will discuss who should and who should not undergo carotid endarterectomy (CE) by focusing on the arterial imaging methods that will provide the essential preoperative information to help ensure appropriate selection of candidates.¹

PATIENTS PROVEN TO BENEFIT FROM CE

The proven indications for . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Clinical Neurological Sciences (Drs Barnett and Eliasziw) and Epidemiology and Biostatistics (Dr Eliasziw), University of Western Ontario; and The John P. Robarts Research Institute, London, Ontario (Drs Barnett and Eliasziw and Ms Meldrum).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?